TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University.
Daiichi Sankyo announced in a news release that a subsidiary in Saitama Prefecture would receive undiluted solution of the potential vaccine known as AZD1222 and then carry out formulation work, packaging and storage in Japan.
